IMS Health — Merger or Acquisition (May 2016)
12 slides from IMS Health's merger presentation, May 4, 2016
Slide 1: Quintiles announces Merger with IMS Health
Quintiles announces Merger with IMS Health Overview for leaders May 3, 2016 For internal use only
Slide 2: Cautionary Notes on Forward Looking Statements
Cautionary Notes on Forward Looking Statements This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this cont
Slide 3: Important Information About the Transaction and Where to Find It
Important Information About the Transaction and Where to Find It In connection with the proposed transaction, IMS Health and Quintiles will be filing documents with the Securities and Exchange Commission (“SEC”), including the filing by Quintiles of a registration statement on Form S-4, and Quintile
Slide 4: Today's news
Today’s news Combined financial view
Slide 5: At a glance: Combined financial view
At a glance Combined financial view $7.2B 2015 Revenue2 $17.6B Market Capitalization1 $1.7B 2015 Adj. EBITDA3 $1.3B 2015 Adj. UFCF4 Transformational Merger of Equals $23.0B Enterprise Value1 As of May 2, 2016 equity market close; net debt as of March 31, 2016 Based on 2015 Quintiles service revenues
Slide 6: Complementary businesses: Best-in-class industry leaders
Complementary businesses Best-in-class industry leaders 2015 Metrics Differentiated Resources Leading Capabilities Revenue: $4.3B Adj. EBITDA / Margin(1): $819M / 19% >1,100 medical doctors, ~1,050 PhDs, ~850 biostatisticians & statistical programmers Quintiles Infosario® platform: >298,000 clinical
Slide 7: World-class talent
World-class talent ~50,000 strong employee base 15,000+ employees serving clients across 100+ countries 1,200+ healthcare informatics experts worldwide 7,000+ employees in commercial services 3,000+ offshore delivery employees Quintiles 36,000+ employees serving clients across 100+ countries 1,100+
Slide 8: Why merge? Client challenges
Why merge? Client challenges Realize Greater R&D Efficiency Demonstrate Value & Measure Outcomes Maximize Commercial ROI $140B+ biopharmaceutical R&D spend per year 1 34% increase since 2010 in cost to develop new drug 2 11.3% clinical success rate (IND Filing to Approval) 2 Increasing study complex
Slide 9: Quintiles IMS Health solutions
Quintiles IMS Health solutions Partner to life sciences Realize Greater R&D Efficiency Demonstrate Value & Measure Outcomes Maximize Commercial ROI Smarter CRO Real World Evidence & Connected Health Technology-Enabled Commercial Operations Equipping therapeutic, scientific, and domain experts from t
Slide 10: World-class clients
World-class clients Top 25 customers measured by 2015 revenue. Retention rates measured from 2014-2015. Largest customer measured by contribution to 2015 revenue. Med Tech & CH Small & Mid Size Pharma Generics Payer / Provider Supplier Chain Government/ non-profit IMS Health: 5,000+ clients Top 25 c
Slide 11: Market opportunity
Market opportunity Estimated >$230B Market Opportunity Growing At 6-8% Growth Drivers Smarter CRO: Need: modernize global trial execution Opportunity: bring information and technology from design through execution of studies Real World Evidence & Connected Health: Need: enable informed dialogue acro
Slide 12: Summary and next steps
Summary and next steps Leader call to action Merger announced Quintiles IMS Health merger announced May 3, 2016 Manage business Integration planning will begin in coming months Stay focused on service delivery Leadership role Disciplined communications Review materials Both companies must operate se
IMS Health Holdings — Merger or Acquisition (May 2016) on 6ix